header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-24071
Fish name: pou5f3m793/m793
Genotype: pou5f3m793/m793
Targeting Reagent: none
HUMAN DISEASE MODELED by pou5f3m793/m793
No data available
GENE EXPRESSION
Gene expression in pou5f3m793/m793
RNA expression
Expressed Gene Structure Conditions Figures
bmp2b standard conditions Fig. 7 with image from Veil et al., 2017
chrd standard conditions Fig. 7 with image from Veil et al., 2017
cyp11a1 standard conditions Fig. 4 from Eckerle et al., 2017
gsc standard conditions Fig. 7 with image from Veil et al., 2017
hsd3b2 standard conditions Fig. 4 from Eckerle et al., 2017
klf2a control Fig. 2Fig. S8 from Leichsenring et al., 2013
krt5 control Fig. S8 from Leichsenring et al., 2013
krt17 control Fig. S8 from Leichsenring et al., 2013
myca standard conditions Fig. 1 with image from Kotkamp et al., 2014
mycb standard conditions Fig. 1 with image from Kotkamp et al., 2014
mych standard conditions Fig. 1 with imageFig. 3 with image from Kotkamp et al., 2014
chemical treatment: pharmaceutical Fig. 3 with image from Kotkamp et al., 2014
mycla standard conditions Fig. 1 with image from Kotkamp et al., 2014
myclb standard conditions Fig. 1 with imageFig. 3 with image from Kotkamp et al., 2014
chemical treatment: pharmaceutical Fig. 3 with image from Kotkamp et al., 2014
sox17 standard conditions Fig. 3 with image from Veil et al., 2017
sox32 standard conditions Fig. 3 with image from Veil et al., 2017
tbxta standard conditions Fig. 1 with imageFig. 3 with image from Kotkamp et al., 2014
chemical treatment: pharmaceutical Fig. 3 with image from Kotkamp et al., 2014
vent standard conditions Fig. 7 with image from Veil et al., 2017
Fig. 1 from Voronina et al., 2016
vox standard conditions Fig. 7 with image from Veil et al., 2017
Fig. 1 from Voronina et al., 2016
Reporter gene expression No data available
PHENOTYPE
Phenotype in pou5f3m793/m793
Phenotype Conditions Figures
apoptotic process increased process quality, abnormal standard conditions Fig. 6 with imageFig. 7 with image from Kotkamp et al., 2014
DEL increased thickness, abnormal standard conditions Fig. 5 with image from Song et al., 2013
DEL epiboly delayed, abnormal standard conditions Fig. 5 with image from Song et al., 2013
endoderm sox17 expression absent, abnormal standard conditions Fig. 3 with image from Veil et al., 2017
epiblast vox expression decreased amount, abnormal standard conditions Fig. 7 with image from Veil et al., 2017
epiblast bmp2b expression decreased amount, abnormal standard conditions Fig. 7 with image from Veil et al., 2017
epiboly arrested, abnormal standard conditions Fig. 5 with image from Kotkamp et al., 2014
Fig. 1 with image from Song et al., 2013
epiboly delayed, abnormal control Fig. 3 with imageFig. 7 with image from Eckerle et al., 2017
Fig. 5 with imageFig. 7 with image from Kotkamp et al., 2014
Fig. 1 with imageFig. 5 with image from Song et al., 2013
epiboly delayed, exacerbated chemical treatment by environment: progesterone Fig. 7 with image from Eckerle et al., 2017
EVL epiboly delayed, abnormal standard conditions Fig. 5 with image from Song et al., 2013
whole organism hsd3b2 expression decreased amount, abnormal standard conditions Fig. 4 from Eckerle et al., 2017
whole organism Ab1-vox labeling decreased amount, abnormal standard conditions Fig. 2 from Voronina et al., 2016
whole organism vent expression decreased amount, abnormal standard conditions Fig. 1 from Voronina et al., 2016
whole organism vox expression decreased amount, abnormal standard conditions Fig. 1 from Voronina et al., 2016
whole organism cyp11a1 expression increased amount, abnormal standard conditions Fig. 4 from Eckerle et al., 2017
whole organism embryo development arrested, abnormal control Fig. 2Fig. S8 from Leichsenring et al., 2013
whole organism pregnenolone increased amount, abnormal control Fig. 4 from Eckerle et al., 2017
whole organism progesterone decreased amount, abnormal control Fig. 4 from Eckerle et al., 2017
whole organism ventral region vent expression decreased amount, abnormal standard conditions Fig. 7 with image from Veil et al., 2017
whole organism ventral region vox expression decreased amount, abnormal standard conditions Fig. 7 with image from Veil et al., 2017
yolk microtubule area density, abnormal control Fig. 3 with imageFig. 7 with image from Eckerle et al., 2017
yolk microtubule area density, ameliorated chemical treatment by environment: progesterone Fig. 7 with image from Eckerle et al., 2017
yolk microtubule structure, abnormal standard conditions Fig. 4 with image from Veil et al., 2017
yolk microtubule bundle formation process quality, abnormal control Fig. 3 with imageFig. 7 with image from Eckerle et al., 2017
yolk microtubule bundle formation process quality, ameliorated chemical treatment by environment: progesterone Fig. 7 with image from Eckerle et al., 2017
yolk microtubule cytoskeleton organization process quality, abnormal control Fig. 3 with image from Eckerle et al., 2017
yolk microtubule polymerization process quality, abnormal control Fig. 3 with image from Eckerle et al., 2017
yolk syncytial layer microtubule area density, abnormal control Fig. 3 with image from Eckerle et al., 2017

CITATIONS  (11)